385 related articles for article (PubMed ID: 26562694)
1. Trends in Male and Female Genital Warts Among Adolescents in a Safety-Net Health Care System 2004-2013: Correlation With Introduction of Female and Male Human Papillomavirus Vaccination.
Perkins RB; Legler A; Hanchate A
Sex Transm Dis; 2015 Dec; 42(12):665-8. PubMed ID: 26562694
[TBL] [Abstract][Full Text] [Related]
2. Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: analysis of national sentinel surveillance data.
Donovan B; Franklin N; Guy R; Grulich AE; Regan DG; Ali H; Wand H; Fairley CK
Lancet Infect Dis; 2011 Jan; 11(1):39-44. PubMed ID: 21067976
[TBL] [Abstract][Full Text] [Related]
3. What can surveillance of genital warts tell us?
Fairley CK; Donovan B
Sex Health; 2010 Sep; 7(3):325-7. PubMed ID: 20719222
[TBL] [Abstract][Full Text] [Related]
4. Incidence of genital warts in adolescents and young adults in an integrated health care delivery system in the United States before human papillomavirus vaccine recommendations.
Camenga DR; Dunne EF; Desai MM; Gee J; Markowitz LE; Desiliva A; Klein NP
Sex Transm Dis; 2013 Jul; 40(7):534-8. PubMed ID: 23965766
[TBL] [Abstract][Full Text] [Related]
5. Impact of Number of Human Papillomavirus Vaccine Doses on Genital Warts Diagnoses Among a National Cohort of U.S. Adolescents.
Perkins RB; Lin M; Wallington SF; Hanchate A
Sex Transm Dis; 2017 Jun; 44(6):365-370. PubMed ID: 28499288
[TBL] [Abstract][Full Text] [Related]
6. Impact of the human papillomavirus (HPV) vaccine on genital wart diagnoses at Auckland Sexual Health Services.
Oliphant J; Perkins N
N Z Med J; 2011 Jul; 124(1339):51-8. PubMed ID: 21952330
[TBL] [Abstract][Full Text] [Related]
7. Time-trend of hospitalizations for anogenital warts in Veneto region in the HPV vaccination era: a cross sectional study (2007-2018).
Cocchio S; Prandi GM; Furlan P; Bertoncello C; Fonzo M; Saia M; Baldovin T; Baldo V
BMC Infect Dis; 2020 Nov; 20(1):857. PubMed ID: 33208109
[TBL] [Abstract][Full Text] [Related]
8. Promising control of genital warts: but is elimination possible?
Lacey CJ; Garnett GP
Lancet Infect Dis; 2011 Jan; 11(1):4-6. PubMed ID: 21183139
[No Abstract] [Full Text] [Related]
9. Impact of quadrivalent human papillomavirus vaccine on genital warts in an opportunistic vaccination structure.
Lurie S; Mizrachi Y; Chodick G; Katz R; Schejter E
Gynecol Oncol; 2017 Aug; 146(2):299-304. PubMed ID: 28602548
[TBL] [Abstract][Full Text] [Related]
10. Genital warts in young Australians five years into national human papillomavirus vaccination programme: national surveillance data.
Ali H; Donovan B; Wand H; Read TR; Regan DG; Grulich AE; Fairley CK; Guy RJ
BMJ; 2013 Apr; 346():f2032. PubMed ID: 23599298
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of vaccination herd immunity effects for anogenital warts in a low coverage setting with human papillomavirus vaccine-an interrupted time series analysis from 2005 to 2010 using health insurance data.
Thöne K; Horn J; Mikolajczyk R
BMC Infect Dis; 2017 Aug; 17(1):564. PubMed ID: 28806926
[TBL] [Abstract][Full Text] [Related]
12. Significant decline of HPV 6 infection and genital warts despite low HPV vaccination coverage in young women in Germany: a long-term prospective, cohort data analysis.
Denecke A; Iftner T; Iftner A; Riedle S; Ocak M; Luyten A; Üye I; Tunc K; Petry KU
BMC Infect Dis; 2021 Jul; 21(1):634. PubMed ID: 34215215
[TBL] [Abstract][Full Text] [Related]
13. Significant Reduction in the Incidence of Genital Warts in Young Men 5 Years into the Danish Human Papillomavirus Vaccination Program for Girls and Women.
Bollerup S; Baldur-Felskov B; Blomberg M; Baandrup L; Dehlendorff C; Kjaer SK
Sex Transm Dis; 2016 Apr; 43(4):238-42. PubMed ID: 26967300
[TBL] [Abstract][Full Text] [Related]
14. Human papillomavirus vaccination and genital warts in young Indigenous Australians: national sentinel surveillance data.
Ali H; McManus H; O'Connor CC; Callander D; Kong M; Graham S; Saulo D; Fairley CK; Regan DG; Grulich A; Low N; Guy RJ; Donovan B
Med J Aust; 2017 Mar; 206(5):204-209. PubMed ID: 28301790
[TBL] [Abstract][Full Text] [Related]
15. The efficacy and safety of the quadrivalent human papillomavirus 6/11/16/18 vaccine gardasil.
Haupt RM; Sings HL
J Adolesc Health; 2011 Nov; 49(5):467-75. PubMed ID: 22018560
[TBL] [Abstract][Full Text] [Related]
16. The incidence of genital warts in Australian women prior to the national vaccination program.
Brotherton JM; Heywood A; Heley S
Sex Health; 2009 Sep; 6(3):178-84. PubMed ID: 19653953
[TBL] [Abstract][Full Text] [Related]
17. Decline in hospitalization for genital warts in the Veneto region after an HPV vaccination program: an observational study.
Cocchio S; Baldovin T; Bertoncello C; Buja A; Furlan P; Saia M; Baldo V
BMC Infect Dis; 2017 Apr; 17(1):249. PubMed ID: 28381294
[TBL] [Abstract][Full Text] [Related]
18. Near elimination of genital warts in Australia predicted with extension of human papillomavirus vaccination to males.
Korostil IA; Ali H; Guy RJ; Donovan B; Law MG; Regan DG
Sex Transm Dis; 2013 Nov; 40(11):833-5. PubMed ID: 24113401
[TBL] [Abstract][Full Text] [Related]
19. Decline in genital warts diagnoses among young women and young men since the introduction of the bivalent HPV (16/18) vaccination programme in England: an ecological analysis.
Canvin M; Sinka K; Hughes G; Mesher D
Sex Transm Infect; 2017 Mar; 93(2):125-128. PubMed ID: 27365492
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of HPV vaccines against genital warts in women from Valencia, Spain.
Navarro-Illana E; López-Lacort M; Navarro-Illana P; Vilata JJ; Diez-Domingo J
Vaccine; 2017 Jun; 35(25):3342-3346. PubMed ID: 28499554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
